<DOC>
	<DOCNO>NCT02651701</DOCNO>
	<brief_summary>The purpose study measure diagnostic performance whole body ( WB ) MR-PET stag rectal cancer , compare current standard care ( chest/abdominopelvic CT rectal MRI ) investigate clinical feasibility WB MR-PET one-stop preoperative imaging modality patient rectal cancer .</brief_summary>
	<brief_title>Rectal Cancer Staging Using Whole Body MR-PET</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>1 . Adult patient newly diagnose rectal cancer colonoscopy sigmoidoscopy , potentially eligible neoadjuvant chemoradiotherapy . 2 . Patients sign inform consent . 1 . Patients contraindication CECT 2 . Patients contraindication MRI/CEMRI 3. patient diagnosed Tis T1 cancer polypectomy EMR 4 . Patients already diagnose active cancer . 5 . Premenopausal female patient pregnant . 6 . Patients fast serum glucose level ( &gt; 200mg/dL ) blood glucose meter prior WB MRPET . 7 . Patients physically compromise undergo WB MRPET .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>